British Journal of Haematology · 2006 · 102 citations · 7 references
MedicineGeneticsHematologyImmunogeneticsMedical GeneticsPharmacogeneticsBone Marrow EvaluationBone Marrow PathologyGenetic DisordersHematopoietic NeoplasmsMyelodysplastic SyndromesMyeloproliferative NeoplasmsBone Marrow ProcessingClonal ExpansionEmergenceJak2 MutationsJak2 V617f MutationMpl MutationsMyeloid DysplasiaMyeloid Neoplasms
MPLW515L/K and JAK2V617F can co-exist in myelofibrosis with myeloid metaplasia (MMM). The chronology of clonal emergence was studied in three such cases using serially stored bone marrow. At diagnosis, a major MPL515 mutant clone was accompanied by a minor JAK2V617F clone in all three instances. At 25 time points over a period of 4-8 years, allele burden fluctuated but remained high for MPLW515L/K and low for JAK2V617F. We conclude that MPLW515L/K and JAK2V617F are both early events in MMM and allele burden, rather than the mere presence of these mutations, might be relevant to phenotypic variation in myeloproliferative disorders.
7
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
Chloé James, Valérie Ugo, Jean‐Pierre Le Couedic et al. · Nature · 2005 · 3.5K citations
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Yana Pikman, Benjamin H. Lee, Thomas Mercher et al. · PLoS Medicine · 2006 · 1.4K citations · Full text
Life Sciences, Genetics, Hematology +14
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
Animesh Pardanani, Ross L. Levine, Terra L. Lasho et al. · Blood · 2006 · 1K citations · Full text
Life Sciences, Genetics, Hematology +14